Monoclonal Antibody Treatments Significantly Reduce Risk Of COVID-19 Hospitalization, Death, Study Finds

Healio (4/5, Feller) reports, “Treatment with a monoclonal antibody within 2 days of a COVID-19 diagnosis reduced the risk for hospitalization or death by almost 40%, according to a study that assessed patient outcomes over a nearly 2-year period.” Result...